Last ¥6,150 JPY
Change Today -170.00 / -2.69%
Volume 400.0
8686 On Other Exchanges
New York
As of 1:50 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

aflac inc (8686) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/27/13 - ¥7,070
52 Week Low
08/28/13 - ¥5,490
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AFLAC INC (8686)

aflac inc (8686) Details

Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The company offers various voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan. It also provides products designed to protect individuals from depletion of assets, which comprise accident, cancer, critical illness/critical care, hospital intensive care, hospital indemnity, fixed-benefit dental, and vision care plans; and loss-of-income products, such as life and short-term disability plans in the United States. The company sells its products through sales associates and brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

9,141 Employees
Last Reported Date: 02/27/14
Founded in 1955

aflac inc (8686) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.4M
President, Chief Financial Officer, Treasurer...
Total Annual Compensation: $951.6K
President of Aflac Japan and Chief Operating ...
Total Annual Compensation: $764.2K
Director, Member of Executive Committee, Memb...
Total Annual Compensation: $633.0K
Executive Vice President of Global Investment...
Total Annual Compensation: $566.5K
Compensation as of Fiscal Year 2013.

aflac inc (8686) Key Developments

AFLAC Inc. Declares Third Quarter Cash Dividend Payable on September 2, 2014

The board of directors of AFLAC Inc. declared the third quarter cash dividend. The third quarter dividend of $0.37 per share is payable on September 2, 2014, to shareholders of record at the close of business on August 20, 2014.

Aflac Incorporated Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Earnings Guidance for the Third Quarter and Full Year 2014

Aflac Incorporated reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported total revenues of USD 5,838 million against USD 6,044 million a year ago. Earnings before income taxes were USD 1,238 million against USD 1,358 million a year ago. Net earnings were USD 810 million or USD 1.78 per diluted share against USD 889 million or USD 1.90 per diluted share a year ago. Operating earnings were USD 757 million or USD 1.66 per diluted share against USD 759 million or USD 1.62 per diluted share a year ago. For the six months, the company reported total revenues of USD 11,478 million against USD 12,252 million a year ago. Earnings before income taxes were USD 2,342 million against USD 2,719 million a year ago. Net earnings were USD 1,542 million or USD 3.38 per diluted share against USD 1,781 million or USD 3.80 per diluted share a year ago. Operating earnings were USD 1,531 million or USD 3.36 per diluted share against USD 1,549 million or USD 3.31 per diluted share a year ago. The company would expect earnings in the third quarter to be approximately USD 1.38 to USD 1.47 per diluted share The company narrowed 2014 initial annual EPS guidance of 2% to 5% per diluted share and currently expects that 2014 operating earnings per diluted share on a currency neutral basis will be up 3% to 4% for the full year. The company would expect full-year reported operating earnings to be about USD 6.16 to USD 6.30 per diluted share.

Aflac Incorporated Names Michael J. Tomlinson as Senior Vice President and Assistant Director of Aflac U.S. Sales

Aflac Incorporated announced that Michael J. Tomlinson has been named senior vice president and assistant director of Aflac U.S. sales, reporting to Thomas R. Giddens, executive vice president and director of Aflac U.S. sales. In his new role, Tomlinson will be responsible for providing leadership and vision as well as driving strategies to advance Aflac's sales throughout the U.S. Tomlinson will focus on the day-to-day operations of the sales force, developing programs and initiatives to support the U.S. sales strategy. Giddens will redirect his efforts to two key areas of focus; recruiting and growing accounts in businesses with less than 100 employees. Tomlinson joined Aflac in 1980 as a sales associate in Minnesota, where he earned Aflac's first-ever Triple Crown Award which recognizes new associates' outstanding sales results.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8686:JP ¥6,150.00 JPY -170.00

8686 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ACE Ltd $100.29 USD +0.19
Cigna Corp $90.61 USD +0.57
Marsh & McLennan Cos Inc $50.65 USD -0.12
Sun Life Financial Inc C$40.89 CAD -0.68
Travelers Cos Inc/The $89.78 USD +0.215
View Industry Companies

Industry Analysis


Industry Average

Valuation 8686 Industry Range
Price/Earnings 9.4x
Price/Sales 1.2x
Price/Book 1.5x
Price/Cash Flow 9.3x
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AFLAC INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at